These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3517276)
1. Parenteral emulsions as drug carrier systems. Singh M; Ravin LJ J Parenter Sci Technol; 1986; 40(1):34-41. PubMed ID: 3517276 [No Abstract] [Full Text] [Related]
2. Evaluation of nanoparticles as drug-delivery systems. II: Comparison of the body distribution of nanoparticles with the body distribution of microspheres (diameter greater than 1 micron), liposomes, and emulsions. Kreuter J Pharm Acta Helv; 1983; 58(8):217-26. PubMed ID: 6622500 [No Abstract] [Full Text] [Related]
3. [Physicochemical incompatibilities of injectable drugs]. Hoffman M; Hazebroucq G Sem Hop; 1983 Feb; 59(8):541-7. PubMed ID: 6302899 [No Abstract] [Full Text] [Related]
4. Coming of age of lipid-based drug delivery systems. Davis SS Adv Drug Deliv Rev; 2004 May; 56(9):1241-2. PubMed ID: 15109766 [No Abstract] [Full Text] [Related]
5. A new scanning electron microscope (SEM) method for the determination of particle size in parenteral fat emulsions. Hamilton-Attwell VL; du Plessis J; van Wyk CJ J Microsc; 1987 Mar; 145(Pt 3):347-9. PubMed ID: 3585996 [TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology. Driscoll DF; Bistrian BR; Demmelmair H; Koletzko B Clin Nutr; 2008 Aug; 27(4):497-503. PubMed ID: 18582994 [No Abstract] [Full Text] [Related]
7. [Possibilities of material contamination due to additional injections]. Müller-Stock A Klin Anasthesiol Intensivther; 1977; (14):114-20. PubMed ID: 926677 [No Abstract] [Full Text] [Related]
8. [Possibilities of material contamination due to additional injections]. Mehrkens HH; Klaus E; Schmitz JE Klin Anasthesiol Intensivther; 1977; (14):106-13. PubMed ID: 926676 [No Abstract] [Full Text] [Related]
9. Use of ultrasound to prepare lipid emulsions of lorazepam for intravenous injection. Medina J; Salvadó A; del Pozo A Int J Pharm; 2001 Mar; 216(1-2):1-8. PubMed ID: 11274800 [TBL] [Abstract][Full Text] [Related]
10. The use of polymers for dermal and transdermal delivery. Valenta C; Auner BG Eur J Pharm Biopharm; 2004 Sep; 58(2):279-89. PubMed ID: 15296955 [TBL] [Abstract][Full Text] [Related]
11. Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. Hwang SR; Lim SJ; Park JS; Kim CK Int J Pharm; 2004 May; 276(1-2):175-83. PubMed ID: 15113624 [TBL] [Abstract][Full Text] [Related]
12. Differences in the coalescence kinetics of fat emulsions in dependence on the amount of fat and age. Harnisch S; Schuhmann R; Harnisch JF; Müller RH Pharmazie; 2002 Jan; 57(1):54-8. PubMed ID: 11836933 [TBL] [Abstract][Full Text] [Related]
13. Tolerance to intravenously administered fat emulsions. HARTWIG QL; COTLAR AM; SHELBY JS; ATIK M; COHN I Surgery; 1961 Mar; 49():308-12. PubMed ID: 13712035 [No Abstract] [Full Text] [Related]
14. Nanosuspensions: a promising drug delivery strategy. Patravale VB; Date AA; Kulkarni RM J Pharm Pharmacol; 2004 Jul; 56(7):827-40. PubMed ID: 15233860 [TBL] [Abstract][Full Text] [Related]